Renowned Speakers

Imran Saleem

Liverpool John Moores University UK

Gary Gellerman

Ariel University Israel

Kang Choon Lee

SungKyunKwan University South Korea

Ruchi Bansal

University of Twente Netherlands

Shilpa Raut

Amway USA

Tina Kauss

University of Bordeaux France

Steve Hood

GSK UK

Andreas Bernkop-SchnÃ¼rch

University of Innsbruck Austria

Recommended Global Pharmaceutical Sciences Webinars & Conferences

Formulations 2024

Welcome Message

Dear Colleagues,

On behalf of the Organizing Committee, it is our distinct pleasure to extend a warm and enthusiastic welcome to the 27th International Conference and Exhibition on Pharmaceutical Formulations (Formulations 2024)! We are thrilled to have you join us for this premier event in the field of Pharmaceuticals.

Formulations 2024 promises to be an exceptional gathering where cutting-edge research, innovative technologies, and invaluable networking opportunities converge. Our dedicated committee has tirelessly worked to curate a program that caters to the diverse interests and expertise of our esteemed participants.

Targer Audience:

Directors, CEO’s of Organizations
Business Development Managers
Chief Scientific Officers
R&D Researchers from Pharmaceutical Industries
Professors, Associate Professors, Assistant Professors
PhD Scholars
Patent Attorneys
Intellectual Property Attorneys
Investment Analysts
Association, Association presidents and professionals
Noble laureates in Health Care and Medicine
Bio instruments Professionals
Bio-informatics Professionals
Software development companies
Research Institutes and members
Supply Chain companies
Manufacturing Companies
CRO and DATA management Companies
Training Institutes
Business Entrepreneurs

About Conference

Conference Series is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing forth “27th International Conference and Exhibition on Pharmaceutical Formulations” (Formulation 2024) scheduled to be held during October 31-November 01, 2024 at Amsterdam, Netherlands. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Formulations.

Conference Series organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Sessions & Tracks

Track 1: Pharmaceutical Formulation

Pharmaceutical formulation is defined as the process in which different chemical substances are combined to produce a final medicinal product. Since 1991, we have been designing Liquid, Suspension, Powder, Solid solution, Semisolid formulations and even drug eluting devices. The formulation studies involve developing a preparation of drug acceptable for patient. Pharmaceutical Formulation is the word often used in a way that includes dosage form. Formulation studies consider factors such as solubility, particle size, polymorphism and pH as all of these can influence bioavailability and hence the activity of a drug.

Related Societies: Belgian Society of Pharmaceutical Sciences (BGFW), European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Association of the British Pharmaceutical Industry (ABPI).

Track 2 : Solid Dosage Forms

Solid dosage formulations are important dosage forms in pharmaceuticals. e.g. tablets, capsules, granules, sachets, reconstitutable powders, powders, dry powder inhalers and chewables. Solid dosage form contains unit dose of one or more medicament. Easy to package and carry around, solid dosage forms are also difficult to tamper with, stable and easy to dose accurately – approximately 80% of errors in medication are associated with the use of liquid formulations. Excipients include Binders, Guidant’s, Sweeteners etc.,

Related Societies: Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC), American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP).

Track 3: Semi-Solid Dosage Forms

Semi solid dosage forms are the products when applied to the skin treat a pathological condition and protects from other harmful environment. They are smooth, non-staining and get miscible with skin secretions. Creams, Gels, Pastes etc. are the examples. Semisolid dosage forms usually are intended for localized drug delivery. In the past few years, however, these forms also have been explored for the systemic delivery of various drugs. Semisolid dosage forms for dermatological drug therapy are intended to produce desired therapeutic action at specific sites in the epidermal tissue.

Related Societies: The Pharmaceutical Society of Australia (PSA), Austrian Pharmaceutical Society (APS), Korean Research-based Pharmaceutical Industry Association (KRPIA), Kuwait Pharmaceutical Association (KPA).

Track 4: Liquid Dosage Forms

Liquid dosage forms are essential Pharmaceutical products which involves a mixture of active drug components and nondrug components (excipients). Liquid dosage forms are prepared: a) by dissolving the active drug substance in an aqueous or non- aqueous (e.g. glycerin, ether, alcohol) solvent b) By suspending the drug in appropriate medium or c) By incorporating the drug substance into an oil or water phase. Ex: Suspension, Emulsion, Syrups, Elixers.

Track 5: Gaseous Dosage Forms

Gaseous dosage forms are packed in a container which gets released upon applying pressure. The gas inside contains therapeutically active medicaments. The containers have valve systems with continuous or limited delivery. They are used for topical application on skin and as local application into nose and mouth.

Track 6: Types of Formulations

Formulations are classified into two types: based on Route of administration and Physical form. Based on route of administration they are classified as Oral, Topical, Rectal, Parenteral, Vaginal, Inhaled, and Ophthalmic and octic. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

Track 7: Novel Drug Dery Systems

“Novel Drug dery System (NDDS) refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug dery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.

Track 8: General Considerations in Dosage Forms

Prior to formulation some physico chemical properties are characterized. Chemical properties include structure, form and reactivity. Physical properties include particle size, melting point and solubility. In case of some drugs biological properties are also characterized. Age and sex of the patient also play a major role in dosage design. The others factors are Solubility, Buffer capacity and partition coefficient.

Track 9: Drug Formulation Procedures

The drug subjected to drug development undergoes number of trials and are screened at different stages to produce a final potent drug for the treatment of various diseases. During this process different properties are checked to see whether the drug is non-toxic to living system and is therapeutic or not. Using suitable excipients and technological preparations the active substances are formulated into final dosage form. The final product is the Actual composition of preparation, manufacturing specification.

Related Societies :The Pharmaceutical Society of Australia (PSA), Austrian Pharmaceutical Society (APS), Korean Research-based Pharmaceutical Industry Association (KRPIA), Kuwait Pharmaceutical Association (KPA).

Track 10: Pharmaceutical Excipients

Pharmaceutical excipients are those substances other than the pro drug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. There are many excipients. Few of them include Anti adherents, Binders, Coatings, Colours, Flavours, Lubricants, Preservatives, Sweeteners etc. Excipients are crucial to drug delivery within the body. Generally, an excipient has no medicinal properties. Its standard purpose is to streamline the manufacture of the drug product and ultimately facilitate physiological absorption of the drug.

Track 11: Drug Design and Development

Drug design, also known as rational drug design, is the inventive process of finding new medications based on the knowledge of a biological target. Drug design defines the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

Track 12: Pharmaceutical Analysis

Pharmaceutical analysis is a branch of practical chemistry that involves a series of process for qualification, purification, identification and determination of a substance, separation of the components of a solution or mixture, or determination of structure of chemical compounds. The sample to be analysed is called as analyse. Pharmaceutical Analysis is an Analytical Method used to determination the quality and quantity of the pharmaceutical products. It also gives the information about the purity and safety of the products. Briefly it can be described as it identifies, determines, quantifies, purifies and separates the active compound from the mixture.

Track 13: Drug Product Manufacturing

The drug product manufacturing facility is designed to produce injectable in syringes or vials in Grade A environment. Industries strive to improve product quality in today’s competitive environment and as well reduce the production cost. Scaling up from our development services to full scale commercial drug product manufacture or transferring existing commercial products we can meet your commercial drug product manufacturing requirements.

Related Societies : Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC), American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP).

Track 14: Smart Drug Dery Systems

Targeted drug dery sometimes called smart drug delivery is a method of during medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to other parts in the meantime reduce side effects/toxicity of payloads which are key factors for improving patient compliance.

Track 15: Pharmacists Role in Patient Safety

Pharmacists can play a role helping patients with chronic diseases have better medication at correct time and get good clinical outcomes. They play a key role in immunization services and identifying vaccine candidates. They Participate and maintain a significant role in multidisciplinary patient care rounds. Patients often make their own decisions about managing their medications. Pharmacists could usefully serve as patient advocates, providing information that permits patients to assess risk and enhance their autonomy.

Track 16: Regulatory Affairs

Regulatory affairs are a new profession which is developed by the governments to protect public health. The main aim is controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals and cosmetics. Regulatory affairs also have a very specific meaning within the healthcare industries.

Track 17: Pharmaceutical Formulations Market

Pharma industries are showing increased confidence in the growth of manufacturing in the market. This turn around in the market is due to the potential which is being driven by concerns of quality in some Asian markets and a marketed shift in the drug development. The primary reason behind this is an increased regulatory confidence in the standards of manufacturing.

Related Societies : Belgian Society of Pharmaceutical Sciences (BGFW), European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Association of the British Pharmaceutical Industry (ABPI).

Track 18: Entrepreneurs Investment Meet

Entrepreneurs who are ready to invest and get profit by working hard in the field of pharmaceutical formulations will be happy by attending this meeting and make their way a successful one by meeting intellectuals and experts who can make their investment worthwhile. This platform will be the best one to make a shape of your business.

Related Societies : The Pharmaceutical Society of Australia (PSA), Austrian Pharmaceutical Society (APS), Korean Research-based Pharmaceutical Industry Association (KRPIA), Kuwait Pharmaceutical Association (KPA).

Market Analysis

Pharmaceutical Formulations Market Research:

Global Pharmaceutical Market 2020 Industry Research Report is a professional and in-depth study on the current state of the Global Pharmaceutical industry. This report studies Global Pharmaceutical in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India with production, revenue, consumption, import and export in these regions, from 2014 to 2020, and forecast to 2025.

The Global Pharmaceutical market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Pharmaceutical market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The global pharmaceuticals market was worth $934.8 billion in 2020 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company.

This is an accelerated pace compared to 5.2% for the years before 2020 but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

The report also focuses on global major leading industry players of Global Pharmaceutical market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Pharmaceutical market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

Formulations Market:

Pharmaceuticals represented a US$500 billion-a-year market globally as of 2020, the World Health Organization states. The global pharmaceutical market is expected to surpass US$800 billion by 2021, with the ten largest pharmaceutical companies collectively commanding about a third of the market. Companies in the pharmaceutical industry are characterized by their sizeable expenditure on R&D and marketing initiatives in a bid to rake in more revenue. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.

Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and niche pharmaceutical companies are now waking up to the lucrative potential that lies in growth markets. Costs associated with bringing new molecules to the commercial space are progressively rising. To add to this, new medicines launches have continued to chart a flat graph. This could, however, also be an enormous opportunity for pharmaceutical companies in both mature and growth markets.

Scope & Importance:

Pharmaceutical marketing is the last element of an information continuum, where research concepts are transformed into practical therapeutic tools and where information is progressively layered and made more useful to the health care system. Thus, transfer of information to physicians through marketing is a crucial element of pharmaceutical innovation. By providing an informed choice of carefully characterized agents, marketing assists physicians in matching drug therapy to individual patient needs. Pharmaceutical marketing is presently the most organized and comprehensive information system for updating physicians about the availability, safety, efficacy, hazards, and techniques of using medicines. The costs of pharmaceutical marketing are substantial, but they are typical of high-technology industries that must communicate important and complex information to sophisticated users. These costs are offset by savings resulting from proper use of medicines and from lower drug costs owing to price competition.

Advanced Drug Delivery Systems

• The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. • The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%. • The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.

Antibiotics

• The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

• The beta-lactams market should reach over $22.0 billion by 2020 from over $20.6 billion in 2015, a CAGR of 1.3% from 2015 to 2020.

• The other antibiotic classes market should reach over $10.6 billion in 2020 from nearly $8.3 billion in 2015, a CAGR of 5.0% from 2015 to 2020.

Excipients in Pharmaceuticals

• The global excipients market should reach nearly $6.9 billion by 2020 from over $6.2 billion in 2015, a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

• The organic excipients market should reach $6.3 billion by 2020 from nearly $5.8 billion in 2015, a CAGR of 1.7% from 2015 to 2020.

• The inorganic excipients market should reach $433.7 million by 2020 from $351.9 million in 2015, a CAGR of 4.3% from 2015 to 2020.

Ophthalmic Therapeutic Drugs

• The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2020, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2020. • The global age-related macular degeneration (AMD) market is expected to grow to nearly $7.9 billion by 2019 from nearly $5.4 billion in 2014, a CAGR of 7.8% from 2014 to 2020. • The global glaucoma therapeutic market generated revenue of $3.8 billion in 2014, and by 2020 this segment is expected to generate $6.4 billion, with a CAGR of 11.1% from 2014 to 2020.

Target Audience:

• Drug Delivery Technology Manufacturers

• Public and Private Physicians

• Healthcare Institutions (Medical Data Centers)

• Research & Clinical Laboratories

• Distributors and Suppliers of Drug Delivery Technologies

• Health Insurance Payers

• Market Research and Consulting Firms

Related Companies/Industries:

Novartis	Roche	Johnson & Johnson	Merck
Sanofi	Pfizer	Bayer	Eli lily
Amgen	AstraZeneca	AbbVie	Celgene
GlaxoSmithKline	Boehringer Ingelheim	Bristol-Myers Squibb	Takeda Pharmaceutical
Otsuka	Novo Nordisk	Gilead Sciences	Biogen Idec
Allergen	Actavis	Shire	Mylan
Actelion	Ipsen	Novozymes	Zoetis

Association & Societies:

Academy of Managed Care Pharmacy (AMCP)
Accreditation Council for Pharmacy Education
Alabama Board of Pharmacy
American Association of Colleges of Pharmacy (AACP)
American Association of Pakistani Pharmaceutical Scientists
American Association of Pharmaceutical Scientists (AAPS)
American Association of Pharmacy Technicians (AAPT)
American College of Clinical Pharmacology
American College of Clinical Pharmacy (ACCP)
American Institute of the History of Pharmacy
American Pharmacists Association (APhA)
American Society for Clinical Pharmacology and Therapeutics
American Society of Consultant Pharmacists (ASCP)
American Society of Health-System Pharmacists
American Society of Pharmacognosy
Arkansas State Board of Pharmacy
Association of Pharmacy Technicians UK
Board of Pharmaceutical Specialties
World Health Organization (WHO)
International Pharmaceutical Federation (FIP)

Past Conference Report

Formulations 2022

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Formulations 2022 Conference the best ever!

The 26^thInternational Conference and Exhibition on Pharmaceutical Formulations, hosted by the Conference Series was held during September 26-27, 2023 as Webinar based on the theme “Novel Approaches and Innovations in Formulations Research”. Benevolent response and active participation were received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pharmaceutics and Drug Delivery Systems, who made this event a grand success.

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Pharmaceutical Formulations

Solid Dosage Forms

Semi-Solid Dosage Forms

Liquid Dosage Forms

Gaseous Dosage Forms

Types of Formulations

Smart Drug Delivery Systems

Pharmacists Role in Patient Safety

Regulatory Affairs

Pharmaceutical Formulations Market

With the grand success of Formulations 2023, Conference Series is proud to announce the “27^thInternational Conference and Exhibition on Pharmaceutical Formulations” to be held during October 31-November 01, 2024 at Amsterdam, Netherlands.

For More details visit: https://formulation.pharmaceuticalconferences.com/

Past Reports Gallery